华昊中天医药-B：法院批准公司委任接管人接管子基金的申请 公司已联系接管人以推进接管程序
BIOSTAR PHARM-BBIOSTAR PHARM-B(HK:02563) Zhi Tong Cai Jing·2025-12-11 15:01

Core Viewpoint - Huahao Zhongtian Pharmaceutical-B (02563) announced the redemption of LFM Stable Income Fund SP, with the Grand Court of the Cayman Islands (Financial Services Court) ruling on December 3, 2025, to appoint a liquidator for the sub-fund [1] Group 1 - The court recognized US-Biostar as a creditor based on the terms of the subscription agreement [1] - The company's legal advisors have communicated with the appointed liquidator to initiate the liquidation and takeover process of the LFM Fund under Cayman Islands law [1] - The company contacted the liquidator on December 10, 2025, to advance the takeover process [1]